Skip to main content
. 2021 Dec 12;11(12):2339. doi: 10.3390/diagnostics11122339

Figure 1.

Figure 1

Boxplots of neurogranin levels in the groups investigated. A (controls), B (Alzheimer), C (cerebrovascular disease), D (inflammatory CNS disease), E (peripheral neuropathy) and F (other neurological diseases).